Robert J. Barr

968 total citations
12 papers, 699 citations indexed

About

Robert J. Barr is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Robert J. Barr has authored 12 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Robert J. Barr's work include Estrogen and related hormone effects (5 papers), Cholesterol and Lipid Metabolism (3 papers) and Computational Drug Discovery Methods (2 papers). Robert J. Barr is often cited by papers focused on Estrogen and related hormone effects (5 papers), Cholesterol and Lipid Metabolism (3 papers) and Computational Drug Discovery Methods (2 papers). Robert J. Barr collaborates with scholars based in United States, Australia and Brazil. Robert J. Barr's co-authors include Ken Pease, Harold E. Osborne, Thomas P. Burris, Kelli Bramlett, Chahrzad Montrose‐Rafizadeh, Venkatesh Krishnan, Chahrzad Montrose, Yong Wang, Jeffrey A. Dodge and Keith A. Houck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Robert J. Barr

11 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Barr United States 10 213 204 160 115 92 12 699
Richard Philpot United States 21 296 1.4× 206 1.0× 33 0.2× 194 1.7× 65 0.7× 51 1.2k
Andrzej Stanisławek Poland 7 369 1.7× 20 0.1× 107 0.7× 412 3.6× 64 0.7× 39 1.1k
Joel Gordon United States 20 433 2.0× 99 0.5× 37 0.2× 73 0.6× 113 1.2× 73 1.3k
Toral Gathani United Kingdom 11 294 1.4× 26 0.1× 178 1.1× 623 5.4× 28 0.3× 26 1.3k
M. van Vliet Netherlands 15 285 1.3× 25 0.1× 159 1.0× 204 1.8× 18 0.2× 35 785
Ji Young Kim South Korea 19 283 1.3× 33 0.2× 36 0.2× 59 0.5× 37 0.4× 41 850
Suman Verma India 8 275 1.3× 23 0.1× 83 0.5× 308 2.7× 137 1.5× 34 888
Ben Liu China 16 429 2.0× 23 0.1× 28 0.2× 87 0.8× 97 1.1× 66 839
Michelle L. O’Brien United States 14 203 1.0× 37 0.2× 71 0.4× 58 0.5× 41 0.4× 27 576
Katie MacDonald Canada 7 130 0.6× 41 0.2× 143 0.9× 249 2.2× 137 1.5× 22 856

Countries citing papers authored by Robert J. Barr

Since Specialization
Citations

This map shows the geographic impact of Robert J. Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Barr more than expected).

Fields of papers citing papers by Robert J. Barr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Barr. The network helps show where Robert J. Barr may publish in the future.

Co-authorship network of co-authors of Robert J. Barr

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Barr. A scholar is included among the top collaborators of Robert J. Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Barr. Robert J. Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bhagwat, Shripad V., Baohui Zhao, Weihua Shen, et al.. (2021). Abstract 1236: Preclinical characterization of LY3484356, a novel, potent and orally bioavailable selective estrogen receptor degrader (SERD). Cancer Research. 81(13_Supplement). 1236–1236. 18 indexed citations
2.
Bleisch, Thomas J., Timothy I. Richardson, Yong Wang, et al.. (2016). Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design. Bioorganic & Medicinal Chemistry Letters. 26(14). 3274–3277. 21 indexed citations
3.
Luz, J.G., Matthew W. Carson, Bradley Condon, et al.. (2015). Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site.. Journal of Medicinal Chemistry. 58(16). 6607–6618. 33 indexed citations
4.
Sindelar, Dana K., Michelle Morin, Janice Shaw, et al.. (2013). LLY-2707, A Novel Nonsteroidal Glucocorticoid Antagonist That Reduces Atypical Antipsychotic–Associated Weight Gain in Rats. Journal of Pharmacology and Experimental Therapeutics. 348(1). 192–201. 7 indexed citations
5.
Sato, Masahiko, Jian‐Liang Lu, Stephen J. Iturria, et al.. (2010). A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia. Journal of Bone and Mineral Research. 25(6). 1326–1336. 18 indexed citations
6.
Dai, Susie Y., Michael J. Chalmers, John B. Bruning, et al.. (2008). Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method. Proceedings of the National Academy of Sciences. 105(20). 7171–7176. 68 indexed citations
7.
8.
Norman, Bryan H., Jeffrey A. Dodge, Timothy I. Richardson, et al.. (2006). Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia. Journal of Medicinal Chemistry. 49(21). 6155–6157. 85 indexed citations
9.
Burris, Thomas P., Chahrzad Montrose, Keith A. Houck, et al.. (2004). The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand. Molecular Pharmacology. 67(3). 948–954. 113 indexed citations
10.
Bramlett, Kelli, Keith A. Houck, Michele Dowless, et al.. (2003). A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor. Journal of Pharmacology and Experimental Therapeutics. 307(1). 291–296. 57 indexed citations
11.
Xu, Yanping, Xiaodong Wang, R. C. Thompson, et al.. (2003). Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist. Journal of Medicinal Chemistry. 46(24). 5121–5124. 52 indexed citations
12.
Barr, Robert J. & Ken Pease. (1990). Crime Placement, Displacement, and Deflection. Crime and Justice. 12. 277–318. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Philpot Breakdown of academic impact, for papers by Andrzej Stanisławek Breakdown of academic impact, for papers by Joel Gordon Breakdown of academic impact, for papers by Toral Gathani Breakdown of academic impact, for papers by M. van Vliet Breakdown of academic impact, for papers by Ji Young Kim Breakdown of academic impact, for papers by Suman Verma Breakdown of academic impact, for papers by Ben Liu Breakdown of academic impact, for papers by Michelle L. O’Brien Breakdown of academic impact, for papers by Katie MacDonald
Rankless by CCL
2026